{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T00:46:32Z","timestamp":1769820392895,"version":"3.49.0"},"reference-count":28,"publisher":"BMJ","issue":"4","funder":[{"name":"St. Michael's Hospital, Toronto, ON","award":["Endowed Chair in Translational Anesthesiology Rese"],"award-info":[{"award-number":["Endowed Chair in Translational Anesthesiology Rese"]}]},{"name":"Department of Anesthesiology and Pain Medicine, University of Toronto, Toronto, ON","award":["Merit Awards"],"award-info":[{"award-number":["Merit Awards"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Reg Anesth Pain Med"],"accepted":{"date-parts":[[2022,11,3]]},"published-print":{"date-parts":[[2023,4]]},"abstract":"<jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Cannabis and cannabinoids continue to gain popularity as adjuncts or alternatives to opioids in pain management, with evolving evidence of effectiveness. The relationship between cannabis and opioid use has previously been investigated in smaller cohorts or ecological samples, but not yet in a nationally representative sample.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A cross-sectional analysis of adults in the USA was undertaken using National Health and Nutrition Examination Survey (NHANES) data from 2009 to 2018. The primary exposure was self-reported use of at least one opioid-containing prescription medication in the 30 days prior to survey administration. The outcome of interest was self-reported cannabis use in the same period. Multivariable logistic regression was used to adjust for sociodemographic and health-related covariates, and NHANES survey sample weights were included in modeling. Prescription opioid users were then subclassified as short-term users (&lt;90 days) or chronic users (\u226590 days) in secondary analysis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A total 10,928 survey respondents were included in analyses, representing 110 million adults in the USA aged 18\u201359. In this weighted cohort, 5.6%\u00b10.4% reported a recent opioid prescription. Among prescription opioid users, 18.4%\u00b13.1% reported recent cannabis use, not significantly different from 17.7%\u00b10.7% among non-users (OR 1.05, 95% CI 0.81 to 1.36, p=0.714). After adjustment for covariates, opioid users were significantly less likely to have recently used cannabis (adjusted OR, aOR 0.70, 95% CI 0.51 to 0.97, p=0.032). When opioid users were subclassified by duration of prescription, there was no detectable difference in recent cannabis use between chronic opioid users and short-term opioid users (aOR 1.11, 95% CI 0.70 to 1.78, p=0.649).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Recent prescription opioid use was associated with decreased odds of cannabis use in this cross-sectional analysis of a nationally representative cohort. These findings suggest that use of cannabis or prescription opioids may not independently promote use of the other.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/rapm-2022-103933","type":"journal-article","created":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T11:40:11Z","timestamp":1671622811000},"page":"145-149","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":7,"title":["Co-use of cannabis and prescription opioids in adults in the USA: a population-based, cross-sectional analysis of the NHANES from 2009 to 2018"],"prefix":"10.1136","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9596-5101","authenticated-orcid":false,"given":"Calvin","family":"Diep","sequence":"first","affiliation":[{"name":"Department of Anesthesiology and Pain Medicine, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akash","family":"Goel","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Pain Medicine, University of Toronto, Toronto, Ontario, Canada"},{"name":"Department of Anesthesia, St Michael's Hospital, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duminda N","family":"Wijeysundera","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Pain Medicine, University of Toronto, Toronto, Ontario, Canada"},{"name":"Department of Anesthesia, St Michael's Hospital, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4975-3823","authenticated-orcid":false,"given":"Hance","family":"Clarke","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Pain Medicine, University of Toronto, Toronto, Ontario, Canada"},{"name":"Department of Anesthesia and Pain Medicine, University Health Network, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karim S","family":"Ladha","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Pain Medicine, University of Toronto, Toronto, Ontario, Canada"},{"name":"Department of Anesthesia, St Michael's Hospital, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2022,12,21]]},"reference":[{"key":"2025101113213912000_48.4.145.1","doi-asserted-by":"crossref","DOI":"10.1016\/j.ypmed.2022.106978","article-title":"The relationship between cannabis use and Legalization frameworks: a cross-sectional analysis using a nationally representative survey","volume":"156","author":"Vachhani","year":"2022","journal-title":"Prev Med"},{"key":"2025101113213912000_48.4.145.2","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.pmn.2019.06.009","article-title":"Cannabis use motivations among adults prescribed opioids for pain versus opioid addiction","volume":"21","author":"Clem","year":"2020","journal-title":"Pain Manag Nurs"},{"key":"2025101113213912000_48.4.145.3","doi-asserted-by":"crossref","DOI":"10.1186\/s10194-018-0862-2","article-title":"Patterns of medicinal cannabis use, strain analysis, and substitution effect among patients with migraine, headache, arthritis, and chronic pain in a medicinal cannabis cohort","volume":"19","author":"Baron","year":"2018","journal-title":"J Headache Pain"},{"key":"2025101113213912000_48.4.145.4","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.01259"},{"key":"2025101113213912000_48.4.145.5","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1089\/can.2017.0012","article-title":"Cannabis as a substitute for Opioid-Based pain medication: patient self-report","volume":"2","author":"Reiman","year":"2017","journal-title":"Cannabis Cannabinoid Res"},{"key":"2025101113213912000_48.4.145.6","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/ADM.0000000000000493","article-title":"Opioid and cannabis Co-Use among adults with chronic pain: relations to substance misuse, mental health, and pain experience","volume":"13","author":"Rogers","year":"2019","journal-title":"J Addict Med"},{"key":"2025101113213912000_48.4.145.7","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.pmn.2019.06.014","article-title":"Cannabis Use and Cognition in Adults Prescribed Opioids for Persistent Pain","volume":"21","author":"Wildes","year":"2020","journal-title":"Pain Manag Nurs"},{"key":"2025101113213912000_48.4.145.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2016.03.002"},{"key":"2025101113213912000_48.4.145.9","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1080\/10826084.2017.1416408","article-title":"Cannabis use is associated with lower odds of prescription opioid analgesic use among HIV-infected individuals with chronic pain","volume":"53","author":"Sohler","year":"2018","journal-title":"Subst Use Misuse"},{"key":"2025101113213912000_48.4.145.10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0187795"},{"key":"2025101113213912000_48.4.145.11","first-page":"1","article-title":"National health and nutrition examination survey, 2015-2018: sample design and estimation procedures","volume":"184","author":"Chen","year":"2020","journal-title":"Vital Health Stat 2"},{"key":"2025101113213912000_48.4.145.12","doi-asserted-by":"crossref","DOI":"10.1002\/mpr.1524","article-title":"The replicability of cannabis use prevalence estimates in the United States","volume":"26","author":"Alshaarawy","year":"2017","journal-title":"Int J Methods Psychiatr Res"},{"key":"2025101113213912000_48.4.145.13","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.6471","article-title":"Self-Reported daily, Weekly, and monthly cannabis use among women before and during pregnancy","volume":"2","author":"Young-Wolff","year":"2019","journal-title":"JAMA Netw Open"},{"key":"2025101113213912000_48.4.145.14","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.2105\/AJPH.2019.305191","article-title":"Post-Legalization opening of retail cannabis stores and adult cannabis use in Washington state, 2009-2016","volume":"109","author":"Everson","year":"2019","journal-title":"Am J Public Health"},{"key":"2025101113213912000_48.4.145.15","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2017.17040413"},{"key":"2025101113213912000_48.4.145.16","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.drugpo.2018.09.002","article-title":"Patients' and clinicians' perspectives of co-use of cannabis and opioids for chronic non-cancer pain management in primary care","volume":"63","author":"Cooke","year":"2019","journal-title":"Int J Drug Policy"},{"key":"2025101113213912000_48.4.145.17","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ypmed.2017.07.008","article-title":"Cannabis use, attitudes, and legal status in the U.S.: a review","volume":"104","author":"Carliner","year":"2017","journal-title":"Prev Med"},{"key":"2025101113213912000_48.4.145.18","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1111\/add.14382","article-title":"Medical cannabis Legalization and opioid prescriptions: evidence on us Medicaid enrollees during 1993-2014","volume":"113","author":"Liang","year":"2018","journal-title":"Addiction"},{"key":"2025101113213912000_48.4.145.19","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.drugpo.2019.09.013","article-title":"The effect of cannabis laws on opioid use","volume":"74","author":"Flexon","year":"2019","journal-title":"Int J Drug Policy"},{"key":"2025101113213912000_48.4.145.20","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1177\/0269881120914211","article-title":"Evaluating the co-use of opioids and cannabis for pain among current users using hypothetical purchase tasks","volume":"34","author":"Bergeria","year":"2020","journal-title":"J Psychopharmacol"},{"key":"2025101113213912000_48.4.145.21","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1001\/jamainternmed.2014.4005","article-title":"Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999-2010","volume":"174","author":"Bachhuber","year":"2014","journal-title":"JAMA Intern Med"},{"key":"2025101113213912000_48.4.145.22","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2017.304059"},{"key":"2025101113213912000_48.4.145.23","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2012.684624"},{"key":"2025101113213912000_48.4.145.24","doi-asserted-by":"publisher","DOI":"10.2174\/138945010790980367"},{"key":"2025101113213912000_48.4.145.25","doi-asserted-by":"crossref","first-page":"n1034","DOI":"10.1136\/bmj.n1034","article-title":"Medical cannabis or cannabinoids for chronic non-cancer and cancer related pain: a systematic review and meta-analysis of randomised clinical trials","volume":"64","author":"Wang","year":"2021","journal-title":"BMJ"},{"key":"2025101113213912000_48.4.145.26","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.addbeh.2017.10.012","article-title":"Cannabis use moderates the relationship between pain and negative affect in adults with opioid use disorder","volume":"77","author":"Wilson","year":"2018","journal-title":"Addict Behav"},{"key":"2025101113213912000_48.4.145.27","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1007\/s40266-021-00893-z","article-title":"Problematic opioid use among older adults: epidemiology, adverse outcomes and treatment considerations","volume":"38","author":"Dufort","year":"2021","journal-title":"Drugs Aging"},{"key":"2025101113213912000_48.4.145.28","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1080\/13607863.2020.1839859","article-title":"Opioid-involved prescription drug misuse and poly-prescription drug misuse in U.S. older adults","volume":"25","author":"Schepis","year":"2021","journal-title":"Aging Ment Health"}],"container-title":["Regional Anesthesia &amp; Pain Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/rapm-2022-103933","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T20:21:51Z","timestamp":1760214111000},"score":1,"resource":{"primary":{"URL":"https:\/\/rapm.bmj.com\/lookup\/doi\/10.1136\/rapm-2022-103933"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,21]]},"references-count":28,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,2,21]]},"published-print":{"date-parts":[[2023,4]]}},"alternative-id":["10.1136\/rapm-2022-103933"],"URL":"https:\/\/doi.org\/10.1136\/rapm-2022-103933","relation":{},"ISSN":["1098-7339","1532-8651"],"issn-type":[{"value":"1098-7339","type":"print"},{"value":"1532-8651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,21]]}}}